22 November 2019 - The Ontario government is proposing drug regulation changes that it says will remove red tape and barriers for pharmaceutical companies, allowing some drugs to bypass the normal approval process during a shortage.

Drug shortages, including the often-used breast cancer drug tamoxifen, have been wide-spread and increasing in recent years.

The move, the government says, would allow alternative drug products to quickly enter the market during a shortage.

Read Ottawa Citizen article